Annotation Detail for YIPF5

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YIPF5 mRNA | decreases expression | 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of YIPF5 mRNA | increases expression | 20106945
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of YIPF5 mRNA | increases expression | 20308225
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.57 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.77 | 16712894 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.01 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.47 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.91 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.91 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.91 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.34 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12639820 12168785 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.42 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.56 | 12676792 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.26 | 12646999 15346721 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.77 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.77 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.12 | 12371664 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.49 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.45 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.90 | 15276417 16712894 17077188 19931552 17306315 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.68 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.32 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.41 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.54 | 17306315 15276417 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.64 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.23 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.87 | 18572023 19524636 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.14 | 12854658 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.64 | 16712894 11723127 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.21 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
5.17 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |